Anti-ZIKV Neutralizing Antibody (V3S-0723-FY194) (CAT#: V3S-0723-FY194)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The clone ZIKV-116 binds to E, DIII and E-FLM. mAb ZIKV-116 binds to an epitope involving residues T309, E393, and K394 on the DIII (DIII-LR) side ridge, which was confirmed by ELISA. Mutations A310E and T335K in DIII-LR reduce binding to DIII. ZIKV-116 was effective against four of the five strains but was inactive against the original African strain MR 766. ZIKV-116 neutralizes ZIKV infection.
Clonality Monoclonal
Host Species Human
Target Species Zika Virus (ZIKV)
Isotype IgG1, kappa

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; WB; Neut

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target ZIKV
Alternative Name Zika virus; ZIKV
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry